Early immunochemotherapy improves survival and CD8 T cell responses in advanced non small cell lung cancer without added toxicity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results